Article

Glycodisplay
Nyheder
New publication from GlycoDisplay scientists

Subpages

News
COVID-19 drug development

Media & Publications

Bioprocessing Summit in Boston

New Publication on GlycoDisplay Technology

Nature Communications publication

Nature Methods publication

Glycodisplay is presenting at Bioprocessing Summit

GlycoDisplay presenting at BioProNet

New Antibody publication from GlycoDisplay scientists

New publication from GlycoDisplay scientists

01. dec 2017

New publication on targeted gene-editing, demonstrating GlycoDisplay's commitment to continous optimization of technologies.

Link: http://www.sciencedirect.com/science/article/pii/S1877117317301370?via%3Dihub

About GlycoDisplay.com

GlycoDisplay develops novel biopharmaceuticals by modifying sugars. The proprietary technology applies targeted cell engineering to display different glycans on cells and proteins. GlycoDisplay is a spin-out from University of Copenhagen, Center for Glycomics, which is world leading within the field of glyco-engineering and glycomics.

Links

Home
Glycodisplay Platform
Services
News
Media and publications
About us
Partners and Investors

Contact

CONTACT US HERE

Call Us Anytime
+45 42703088
Email Us At
info@glycodisplay.com

Toy illustration by Lise Grastrup